Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2006-06-13
2006-06-13
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S268100, C435S069100, C435S069300, C435S069700, C435S071200, C435S235100, C435S320100, C435S070100, C435S070200, C536S023500, C536S023700, C536S024320
Reexamination Certificate
active
07060276
ABSTRACT:
In this application is described the expression and purification of a recombinantPlasmodium falciparum(3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
REFERENCES:
patent: 5766597 (1998-06-01), Paoletti et al.
patent: 6417341 (2002-07-01), Anders et al.
Infection and Immunity 64: 3833-3844.
J.B.C, 1996, vol. 271, 29446-29452.
J.B.C. 1997 vol. 272, No. 41, Issue of pp. 25678-25684.
Infection and Immunity 1996, 64: 1054-1059.
Vaccine 2002, 20, 2263-2277.
Vaccine 2003, 21, 1650-1657.
Parasite Immunology 2003, 25, 17-25.
Vaccine 2003, 22, 30-41.
Abbott et al., 1999, Purification of soluble, stable recombinantPlasmodium falciparumAMA from bacteria. American Journal of Tropical medicine and Hygiene 61, Suppl. p. 298.
Narum et al., 1994. Differential localization of full-length and processed froms of PF83/AMA-1 and apical membrane antigen ofPlasmodium falciparummerozoites. Mol. Biochem. Parasitol. 67, 59-68.
Kocken et al., 1999. High-level expression ofPlasmodium vivaxapical membrane antigen 1 (AMA-1) inPichia pastoris:strong immunogenicity in Macaca mulatta immunized withP. vivaxAMA-1 and adjuvant SBAS2. Infec. Immun. 67, No. 1, pp. 43-49.
Narum et al., 1993. Ion-exchange-immunoaffinity purification of a recombinant baculovirusPlasmodium falciparumapical membrane antigigen Pf83/AMA-1. J. Chromatography 657, 357-363.
Dutta, et al. 2002. Purification, characterization, and immunogenicity of the refolded ectodomain of thePlasmodium falciparumapical membrane antigen 1 expressed inEscherichia coli.Infection and Immunity 70, 3101-3110.
Dutta Sheetij
Lanar David E.
Nair Lalitha P. V.
Ware Lisa A.
Arwine Elizabeth
Baskar Padma
Smith Lynette R. F.
The United States of America as represented by the Secretary of
LandOfFree
Plasmodium falciparum AMA-1 protein and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasmodium falciparum AMA-1 protein and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmodium falciparum AMA-1 protein and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3664019